Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.

Human SLAMF1/SLAM/CD150 Protein

Human SLAMF1/SLAM/CD150 Protein

CAT#: ICP-A002

Inquiry

Overview Specification

Species	Human
Tag	C-His
Expression Systems	Expi293
Keywords	Human; C-His; Expi293

Synonyms	CDw150; IPO-3; CD150; SLAMF1; SLAM
Background	The signaling lymphocytic activation molecule (SLAM) family comprises nine distinct receptors (SLAMF1 through SLAMF9) expressed on hematopoietic cells. The SLAM family receptor function is primarily controlled via SLAM-associated protein (SAP) family adaptors. The SAP family adaptors consist of SAP, Ewing sarcoma-associated transcript (EAT)-2, and EAT-2-related transducer (ERT).
Source	Recombinant Human SLAMF1/SLAM/CD150 Protein is expressed from Expi293 with His tag at the C-terminal. It contains Ala21-Pro237.
Molecular Weight	The protein has a predicted MW of 25.4 kDa. Due to glycosylation, the protein migrates to 40-60 kDa based on Tris-Bis PAGE result.
Endotoxin	Less than 1 EU per μg by the LAL method.
Purity	>95% as determined by Tris-Bis PAGE. >95% as determined by HPLC.
Formulation	Supplied as 0.22 μm filtered solution in PBS (pH 7.4). Please dilute to the desired concentration according to the concentration of the solution shown on the product label.
Storage	Valid for 12 months from date of receipt when stored at -80℃.
Notes	Recommend to aliquot the protein into smaller quantities for optimal storage. Please do not repeated freeze-thaw cycles.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Online Inquiry

Alfa Cytology provides its clients with one-stop solutions to accelerate therapeutic discovery and development of brain tumors.

By Disease

Craniopharyngioma

Schwannoma (neuroma)

Pituitary Tumors

Choroid Plexus Tumors

By Molecule Type

Small Molecule Drug

Therapeutic Antibody

Immune Cell Therapy

Oncolytic Virotherapy

Vaccine Development

Contact Us

Copyright © 2024 Alfa Cytology. All rights reserved.